Los Angeles, California, United States Funds with similar focus
| Fund Name | Location |
| Alcazar Capital | Dubai, United Arab Emirates |
| Arcus Infrastructure Partners | England, London, United Kingdom |
| Averroes Ventures | Al Qahirah, Cairo, Egypt |
| Community Futures | Canada, Cornwall, Prince Edward Island |
| Gaja Capital | India, Maharashtra, Mumbai |
| Hangzhou Meisheng Aibi Wenhua Fazhan Youxian Gongsi | China, Hangzhou, Zhejiang |
| Henry Crown and Company | - |
| ICONIQ Growth | California, San Francisco, United States |
| IPGL | England, London, United Kingdom |
| Ludgate Environmental Fund | Kersey, Lancashire, United Kingdom |
| McCown De Leeuw & Co | California, Foster City, United States |
| MicroPort Scientific | - |
| National Treasury Management Agency (NTMA) | County Dublin, Dublin, Ireland |
| Owens Corning | Ohio, Toledo, United States |
| Quaker Capital Investments | - |
| Shanghai Kairong Investment Management | China, Shanghai |
| Southern Funds Group | Houston, Texas, United States |
| Thomas Weisel Partners | California, San Francisco, United States |
| Weizhong Xiang Jijin | China, Jiangsu, Nanjing |
| Wellington Underwriting | England, London, United Kingdom |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Synta Pharmaceuticals | $50M | 14 Jan 2004 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Synta Pharmaceuticals | $50M | 14 Jan 2004 | Massachusetts, United States |
